bibliographicCitation |
Weir MR, Sperling RS, Reicin A, Gertz BJ. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Am Heart J. 2003 Oct;146(4):591–604. doi: 10.1016/s0002-8703(03)00398-3. PMID: 14564311. |